Bleeding During Veno-Venous ECMO: Prevention and Treatment.

Area of Science:

• Critical Care Medicine
• Cardiopulmonary Support
• Hematology

Background:

• Veno-venous extracorporeal membrane oxygenation (vvECMO) is a standard therapy for severe respiratory failure.
• Bleeding complications occur frequently in 30-60% of patients on vvECMO.
• Hemorrhage significantly increases mortality risk by 2-3 fold.

Purpose of the Study:

• To review the mechanisms of bleeding pathologies during vvECMO.
• To outline the diagnostic and therapeutic pathways for managing bleeding in vvECMO patients.

Main Methods:

• Literature review focusing on pathophysiology of bleeding during vvECMO.
• Analysis of factors contributing to acquired bleeding disorders.
• Synthesis of current diagnostic and treatment strategies.

Main Results:

• Bleeding is multifactorial, involving anticoagulation and extracorporeal circuit-induced coagulopathy.
• Specific acquired bleeding disorders arise from mechanical pump and foreign surface interactions.
• A clear diagnostic and treatment algorithm is essential for patient management.

Conclusions:

• Understanding the complex mechanisms of bleeding is vital for effective vvECMO management.
• Prompt diagnosis and tailored treatment can mitigate bleeding risks and improve outcomes.
• Further research into anticoagulation and circuit-related coagulopathy is warranted.